Suspected triple co-infection with SARS-CoV-2, Legionella pneumophila, and Streptococcus pneumoniae after hot-spring travel: a case report
Exploration of Medicine · 17.08.2026 · 7
DOI: 10.37349/emed.2026.1001424 ↗Kurz gefasst
Fallbericht in der Zeitschrift Exploration of Medicine, online erschienen am 17.08.2026. Verfasst von Ryutaro Hirose und 11 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial co-infection in patients with coronavirus disease 2019 (COVID-19) can complicate diagnosis because of overlapping clinicoradiologic findings among pathogens. We report a case of suspected triple co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Legionella pneumophila (L. pneumophila), and Streptococcus pneumoniae (S. pneumoniae) after hot-spring travel in a post-splenectomy patient. A man in his 70s with a history of subtotal esophagectomy and concomitant splenectomy for esophageal cancer was admitted with fever, worsening productive cough, and altered sensorium. He had recently traveled to a hot spring with a group that included his wife, who also developed a fever and was diagnosed with COVID-19. On admission, results of urinary antigen tests for L. pneumophila and S. pneumoniae were positive, a SARS-CoV-2 nucleic acid amplification test was positive, and sputum culture yielded S. pneumoniae. Chest computed tomography revealed multifocal bilateral ground-glass opacities, small bilateral pleural effusions, and relatively well-defined right middle-lobe consolidation with air bronchograms in a peribronchovascular distribution. These microbiological and radiological findings supported a suspected triple co-infection rather than COVID-19 alone. Treatment with remdesivir, ceftriaxone, and levofloxacin was initiated, and the patient’s condition improved, with better oxygenation and decreased inflammatory markers. Remdesivir and ceftriaxone were discontinued after 5 days, whereas levofloxacin was continued for 14 days. Follow-up imaging revealed marked improvement, and the patient was discharged. Public health investigations did not detect Legionella at the hot-spring facility or identify any additional linked cases. This case highlights the importance of prompt pathogen-directed evaluation when COVID-19 pneumonia is accompanied by a relevant exposure history, host risk factors, and atypical imaging findings.
Zitieren
APA
Hirose, R., Takahashi, H., Yasuda, T., Taguchi, K., Furukawa, K., Satake, Y., Nagamatsu, H., Toba, N., Toyama-Kousaka, M., Ota, S., Morikawa, M., & Shinkai, M. (2026). Suspected triple co-infection with SARS-CoV-2, Legionella pneumophila, and Streptococcus pneumoniae after hot-spring travel: a case report. Exploration of Medicine, 7. https://doi.org/10.37349/emed.2026.1001424
Vancouver
Hirose R, Takahashi H, Yasuda T, Taguchi K, Furukawa K, Satake Y, et al. Suspected triple co-infection with SARS-CoV-2, Legionella pneumophila, and Streptococcus pneumoniae after hot-spring travel: a case report. Exploration of Medicine. 2026;7. doi:10.37349/emed.2026.1001424
BibTeX
@article{Hirose2026,
author = {Hirose, Ryutaro and Takahashi, Hidenori and Yasuda, Takumi and Taguchi, Kota and Furukawa, Kanako and Satake, Yugo and Nagamatsu, Hiroki and Toba, Naoya and Toyama-Kousaka, Mio and Ota, Shinichiro and Morikawa, Miwa and Shinkai, Masaharu},
title = {Suspected triple co-infection with SARS-CoV-2, Legionella pneumophila, and Streptococcus pneumoniae after hot-spring travel: a case report},
journal = {Exploration of Medicine},
year = {2026},
volume = {7},
doi = {10.37349/emed.2026.1001424}
}
EUVIMED